Australia (AU)

WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comperat E, et al. Journal article In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting FOXP2 (2022) Morison LD, Meffert E, Stampfer M, Steiner-Wilke I, Vollmer B, Schulze K, Briggs T, et al. Journal article Evidence of ACL healing on MRI following ACL rupture treated with rehabilitation alone may be associated with better patient-reported outcomes: a secondary analysis from the KANON trial (2022) Filbay SR, Roemer F, Lohmander LS, Turkiewicz A, Roos EM, Frobell R, Englund M Journal article In-fibre second-harmonic generation with embedded two-dimensional materials (2022) Ngo GQ, Najafidehaghani E, Gan Z, Khazaee S, Siems MP, George A, Schartner EP, et al. Journal article WHO working definition of vitality capacity for healthy longevity monitoring (2022) Bautmans I, Knoop V, Thiyagarajan JA, Maier AB, Beard JR, Freiberger E, Belsky D, et al. Journal article GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution Global Matrix 4.0 Physical Activity Report Card Grades for Children and Adolescents: Results and Analyses From 57 Countries (2022) Aubert S, Barnes JD, Demchenko I, Hawthorne M, Abdeta C, Nader PA, Sala JCA, et al. Journal article Growth of the upper crust in intra-oceanic island arcs by intrusion of basaltic magmas: the case of the Koloula Igneous Complex, Guadalcanal, Solomon Islands (SW Pacific) (2022) Sotiriou P, Haase K, Schneider K, Grosche A, Nöbel K, Chivas AR Journal article Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 (2022) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kuemmel S, Bergh J, et al. Conference contribution Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article